Skip to main content
Figure 4 | Arthritis Research & Therapy

Figure 4

From: Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

Figure 4

Comparison of HMGB1 levels during follow-up in relapsing and nonrelapsing AAV patients. Using a generalized estimating equation model, no significant differences were found between relapsing (n = 17) and nonrelapsing (n = 32) antineutrophil cytoplasmic antibodies-associated vasculitis (AAV) patients regarding longitudinal levels of high-mobility group box 1 (HMGB1) (P = 0.350).

Back to article page